NSE BSE
astrazeneca pharma ind lt stock

ASTRAZENECA PHARMA IND LT Share Price

- - (%)
- NSE: ASTRAZEN

ASTRAZENECA PHARMA IND LT Share Price Update

As of the latest trading session, ASTRAZENECA PHARMA IND LT share price is currently at 6458.45, which is down by -107.34 from its previous closing. Today, the stock has fluctuated between 6431.95 and 6615.55. Over the past year, ASTRAZENECA PHARMA IND LT has achieved a return of 72.80 %. In the last month alone, the return has been 1.96 %. Read More...

ASTRAZENECA PHARMA IND LT Performance

Day Range

Low6431.95 High6615.55
6565.80

52 Week Range

Low 3730.25 High 7572.20
6565.80

ASTRAZENECA PHARMA IND LT Share Price

5610

506820

ASTRAZEN

img img img img
No Data Available

Open Price

6565.80

Prev. Close

6565.80

Volume (Shares)

15691.00

Total traded value

1030.23

Upper Circuit

7878.95

Lower Circuit

5252.65

Note: The current prices & values are delayed, Login to your account for live updates.

ASTRAZENECA PHARMA IND LT Fundamentals


(Standalone)

Market Cap (Cr) 16414.50
PE Ratio (TTM) 101.65
Book Value / Share 284.76
Beta 0.76
ROE 24.84%
EPS (TTM) 59.80
Dividend Yield 0.37%
Net Profit Qtr (Cr) 39.48

ASTRAZENECA PHARMA IND LT Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 1295.53
Operating Expense 1127.22
Net Profit 161.51
Net Profit Margin (%) 12.46
Earnings Per Share (EPS) 64.00
EBITDA 235.67
Effective Tax Rate (%) 26.43
Particulars MAR 2023 (Values in Cr)
Revenue 1002.97
Operating Expense 854.74
Net Profit 99.29
Net Profit Margin (%) 9.89
Earnings Per Share (EPS) 39.72
EBITDA 150.98
Effective Tax Rate (%) 25.95
Particulars MAR 2022 (Values in Cr)
Revenue 805.60
Operating Expense 737.32
Net Profit 61.59
Net Profit Margin (%) 7.64
Earnings Per Share (EPS) 24.64
EBITDA 100.94
Effective Tax Rate (%) 25.81
Particulars MAR 2021 (Values in Cr)
Revenue 813.56
Operating Expense 699.31
Net Profit 93.30
Net Profit Margin (%) 11.46
Earnings Per Share (EPS) 37.32
EBITDA 148.31
Effective Tax Rate (%) 26.58
Particulars MAR 2020 (Values in Cr)
Revenue 831.81
Operating Expense 730.83
Net Profit 72.22
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 28.89
EBITDA 133.69
Effective Tax Rate (%) 36.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 284.77
ROE % 24.84
ROCE % 33.26
Total Debt to Total Equity 0.01
EBITDA Margin 18.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 235.48
ROE % 22.95
ROCE % 30.47
Total Debt to Total Equity 0.01
EBITDA Margin 18.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 204.56
ROE % 12.73
ROCE % 16.76
Total Debt to Total Equity 0.02
EBITDA Margin 12.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 182.47
ROE % 22.74
ROCE % 29.94
Total Debt to Total Equity 0.03
EBITDA Margin 18.23
Particulars MAR 2020 (Values in Cr)
Book Value / Share 145.78
ROE % 21.71
ROCE % 33.63
Total Debt to Total Equity 0.02
EBITDA Margin 16.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 505.84
Total Assets 1078.03
Total Liabilities 1078.03
Total Equity 711.92
Share Outstanding 25000000
Price to Book Ratio 18.68
Return on Assets (%) 14.98
Return on Capital (%) 22.69
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 500.48
Total Assets 984.87
Total Liabilities 984.87
Total Equity 588.69
Share Outstanding 25000000
Price to Book Ratio 13.79
Return on Assets (%) 10.08
Return on Capital (%) 16.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 448.46
Total Assets 856.56
Total Liabilities 856.56
Total Equity 511.39
Share Outstanding 25000000
Price to Book Ratio 12.49
Return on Assets (%) 7.19
Return on Capital (%) 12.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 352.35
Total Assets 774.71
Total Liabilities 774.71
Total Equity 456.17
Share Outstanding 25000000
Price to Book Ratio 16.50
Return on Assets (%) 12.04
Return on Capital (%) 20.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 252.52
Total Assets 706.36
Total Liabilities 706.36
Total Equity 364.44
Share Outstanding 25000000
Price to Book Ratio 16.41
Return on Assets (%) 10.22
Return on Capital (%) 19.81
Particulars MAR 2024 (Values in Cr)
Net Income 219.54
Cash from Operations 84.30
Cash from Investing 21.74
Cash from Financing -44.38
Net change in Cash 5.23
Free Cash Flow 95.06
Particulars MAR 2023 (Values in Cr)
Net Income 134.10
Cash from Operations 99.11
Cash from Investing 18.11
Cash from Financing -24.48
Net change in Cash 51.92
Free Cash Flow 107.63
Particulars MAR 2022 (Values in Cr)
Net Income 83.04
Cash from Operations 125.59
Cash from Investing 4.74
Cash from Financing -9.46
Net change in Cash 96.08
Free Cash Flow 135.21
Particulars MAR 2021 (Values in Cr)
Net Income 127.09
Cash from Operations 137.34
Cash from Investing 173.03
Cash from Financing -8.97
Net change in Cash 268.84
Free Cash Flow 145.05
Particulars MAR 2020 (Values in Cr)
Net Income 113.97
Cash from Operations 121.06
Cash from Investing -170.80
Cash from Financing -6.36
Net change in Cash -89.74
Free Cash Flow 135.28
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
SANOFI INDIA LIMITED 6388.45 25.93 14.49 14712.60 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15
CIPLA LTD 1511.35 32.86 4.36 122044.23 1020.00 / 1581.70

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 6695.00
  • 26 Days 6555.70
  • 10 Days 6677.80
  • 50 Days 6263.90
  • 12 Days 6649.80
  • 100 Days 5955.50
  • 20 Days 6614.10
  • 200 Days 4758.70
6658.77
PIVOT
First Resistance 6741.98
Second Resistance 6873.22
Third Resistance 6956.43
First Support 6527.53
Second Support 6444.32
Third Support 6313.08
RSI 53.91
MACD 94.15
Commodity Channel Index (CCI) 22.84
ADX 55.73
Williams % R -70.76

Over 1 Month

down

1.96

Over 3 Months

down

24.23

Over 6 Months

down

4.38

Over 1 Year

down

72.80

Over 3 Years

down

23.12

Over 5 Years

down

26.77

ASTRAZENECA PHARMA IND LT Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ASTRAZENECA PHARMA IND LT Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
18.51
Promoter Holdings
75.0
FII
2.73
DII
3.74
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Astrazeneca Pharmaceuticals Ab Shareholding of Promoter and Promoter Group 1.875E7 75.0
Nippon Life India Trustee Ltd - Various Schemes Public Shareholding 720255.0 2.88
Tejas Bhalchandra Trivedi Public Shareholding 679078.0 2.72
Shivani Tejas Trivedi Public Shareholding 608636.0 2.43
Minaxi Bhalchandra Trivedi Public Shareholding 460720.0 1.84

ASTRAZENECA PHARMA IND LT

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-14 16.0 Final 2023-07-14 Equity shares 2022-07-07 8.0 Final 2022-07-08 Equity shares 2021-08-18 2.0 Interim 2021-08-20 Equity shares 2020-08-20 2.0 Interim 2020-08-21 Equity shares 2019-08-20 1.0 Interim 2019-08-21 Equity shares 2012-07-09 3.5 Final 2012-07-11 Equity shares 2011-07-07 10.0 Final 2011-07-09 Equity shares 2010-05-06 10.0 Final 2010-05-08 Equity shares 2009-04-30 15.0 Final 2009-05-05 Equity shares 2008-04-11 15.0 Final 2008-04-16 Equity shares 2007-03-22 12.0 Interim 2007-03-24 Equity shares 2006-04-12 0.0 Final 2006-04-14 Equity shares
Ex-Date Ex-Bonus Ratio
1995-11-19 1995-11-13 1:1
Ex-Date Old FV NEW FV Record Date
2006-06-15 10.0 2.0 2006-06-22

Learn More About Stocks

About ASTRAZENECA PHARMA IND LT

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ASTRAZENECA PHARMA IND LT

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Astrazeneca Pharma India Ltd?

Answer Field

The share price of Astrazeneca Pharma India Ltd for NSE is ₹ 6458.45 and for BSE is ₹ 6431.7.

What is the Market Cap of Astrazeneca Pharma India Ltd?

Answer Field

The market cap of Astrazeneca Pharma India Ltd for NSE is ₹ 16,414.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Astrazeneca Pharma India Ltd?

Answer Field

The 52 Week High and Low of Astrazeneca Pharma India Ltd for NSE is ₹ 7572.20 and ₹ 3730.25 and for BSE is ₹ 7550.00 and ₹ 3715.05.

How to Buy Astrazeneca Pharma India Ltd share?

Answer Field

You can trade in Astrazeneca Pharma India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Astrazeneca Pharma India Ltd?

Answer Field

The 1 year returns on the stock has been 72.80%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader